BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16622880)

  • 1. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene.
    Weber B
    J Med Virol; 2006; 78 Suppl 1():S59-65. PubMed ID: 16622880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact.
    Weber B
    J Clin Virol; 2005 Feb; 32(2):102-12. PubMed ID: 15653412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay.
    Echevarría JM; Avellón A
    J Med Virol; 2008 Apr; 80(4):598-602. PubMed ID: 18297712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
    Weber B; Van der Taelem-Brulé N; Berger A; Simon F; Geudin M; Ritter J
    J Virol Methods; 2006 Jul; 135(1):109-17. PubMed ID: 16567005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
    Weber B
    Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
    La'ulu SL; Roberts WL
    Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Yamaguchi K
    J Virol Methods; 2006 Sep; 136(1-2):254-6. PubMed ID: 16707169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.
    Moerman B; Moons V; Sommer H; Schmitt Y; Stetter M
    Clin Lab; 2004; 50(3-4):159-62. PubMed ID: 15074469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection.
    Scheiblauer H; Soboll H; Nick S
    J Med Virol; 2006; 78 Suppl 1():S66-70. PubMed ID: 16622881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HBs antigen mutants: prevalence, clinical and diagnostic implications].
    Roque-Afonso AM; Ferey MP; Belkhiri D; Dussaix E
    Pathol Biol (Paris); 2005; 53(8-9):563-8. PubMed ID: 16099111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for hepatitis B surface antigen mutants.
    Coleman PF
    J Med Virol; 2006; 78 Suppl 1():S56-8. PubMed ID: 16622879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HBsAg mutants.
    Osiowy C
    J Med Virol; 2006; 78 Suppl 1():S48-51. PubMed ID: 16622877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
    Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
    J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.
    Tian Y; Xu Y; Zhang Z; Meng Z; Qin L; Lu M; Yang D
    J Clin Microbiol; 2007 Sep; 45(9):2971-8. PubMed ID: 17609325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.
    Zheng X; Weinberger KM; Gehrke R; Isogawa M; Hilken G; Kemper T; Xu Y; Yang D; Jilg W; Roggendorf M; Lu M
    Virology; 2004 Nov; 329(2):454-64. PubMed ID: 15518823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
    Sayiner AA; Ozcan A; Sengonul A
    J Med Virol; 2008 Mar; 80(3):405-10. PubMed ID: 18205223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.